JW Shinyak Corp
KOSDAQ:067290
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
JW Shinyak Corp
Operating Income
JW Shinyak Corp
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
J
|
JW Shinyak Corp
KOSDAQ:067290
|
Operating Income
₩7.5B
|
CAGR 3-Years
20%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
5%
|
|
|
Yuhan Corp
KRX:000100
|
Operating Income
₩104.4B
|
CAGR 3-Years
43%
|
CAGR 5-Years
4%
|
CAGR 10-Years
2%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Operating Income
₩203.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Operating Income
₩257.8B
|
CAGR 3-Years
18%
|
CAGR 5-Years
39%
|
CAGR 10-Years
2%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Operating Income
₩8.5B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
9%
|
CAGR 10-Years
-9%
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Operating Income
₩20.4B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
JW Shinyak Corp
Glance View
JW SHINYAK Corp. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Seoul, Seoul. The company went IPO on 2003-02-11. The Company’s main products portfolio consists of antibiotics, anesthetics, respiratory remedies, urology remedies, cardiovascular remedies, allergy remedies, digestive remedies, anti-inflammatory drugs, antivirals as well as acne remedies, among others. In addition, it also involves in the provision of cosmetics, such as creams, cleansers, toners, essences, lotions and others.
See Also
What is JW Shinyak Corp's Operating Income?
Operating Income
7.5B
KRW
Based on the financial report for Dec 31, 2025, JW Shinyak Corp's Operating Income amounts to 7.5B KRW.
What is JW Shinyak Corp's Operating Income growth rate?
Operating Income CAGR 10Y
5%
Over the last year, the Operating Income growth was -25%. The average annual Operating Income growth rates for JW Shinyak Corp have been 20% over the past three years , and 5% over the past ten years .
